VSEE HEALTH, INC. (VSEE) — Institutional Holders, Q2 2026
20 institutional investment managers reported a VSEE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $767.8K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
VSEE in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
New positions
9
Added to
4
Trimmed
3
Sold out
0
Biggest buyers
- JANE STREET GROUPNew · +785,322 sh+$90.8K
- ARMISTICE CAPITALAdded · +580,902 sh+$67.2K
- VANGUARD FIDUCIARYNew · +354,298 sh+$41.0K
- HRT FINANCIALNew · +317,924 sh+$36.8K
- OSAICNew · +99,785 sh+$11.5K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -230,518 sh-$26.6K
- UBS Group AGTrimmed · -17,138 sh-$2.0K
- Tower Research Capital (TRC)Trimmed · -578 sh-$67.00
VSEE 13F holders ranked 1–20 of 20
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL#1 · 4,079,129 sh | 4,079,129 | $471.5K | <0.01% | +16.6% |
| 2 | JANE STREET GROUP#2 · 785,322 sh | 785,322 | $90.8K | 0.00% | New |
| 3 | VANGUARD FIDUCIARY#3 · 354,298 sh | 354,298 | $41.1K | 0.00% | New |
| 4 | HRT FINANCIAL#4 · 317,924 sh | 317,924 | $36.0K | <0.01% | New |
| 5 | VANGUARD CAPITAL MANAGEMENT#5 · 213,716 sh | 213,716 | $24.8K | 0.00% | 0.0% |
| 6 | GEODE CAPITAL MANAGEMENT#6 · 207,081 sh | 207,081 | $23.9K | 0.00% | -52.7% |
| 7 | Cygnus Capital Advisors#7 · 142,908 sh | 142,908 | $17.0K | 0.01% | +19.1% |
| 8 | XTX Topco Ltd#8 · 129,160 sh | 129,160 | $14.9K | <0.01% | +142.7% |
| 9 | Virtu Financial#9 · 105,998 sh | 105,998 | $12.0K | <0.01% | +262.7% |
| 10 | OSAIC#10 · 99,785 sh | 99,785 | $12.0K | 0.00% | New |
| 11 | TWO SIGMA SECURITIES#11 · 73,029 sh | 73,029 | $8.4K | <0.01% | New |
| 12 | CITADEL ADVISORS#12 · 33,557 sh | 33,557 | $3.9K | 0.00% | New |
| 13 | NORTHERN#13 · 27,373 sh | 27,373 | $3.2K | 0.00% | New |
| 14 | STATE STREET#14 · 18,900 sh | 18,900 | $2.2K | 0.00% | 0.0% |
| 15 | UBS Group AG#15 · 18,022 sh | 18,022 | $2.1K | 0.00% | -48.7% |
| 16 | GOLDMAN SACHS GROUP#16 · 14,932 sh | 14,932 | $1.7K | 0.00% | New |
| 17 | Wealthcare Advisory Partners#17 · 14,098 sh | 14,098 | $1.6K | — | 0.0% |
| 18 | Tower Research Capital (TRC)#18 · 4,020 sh | 4,020 | $465.00 | 0.00% | -12.6% |
| 19 | BARCLAYS PLC#19 · 1,526 sh | 1,526 | $176.00 | 0.00% | New |
| 20 | SBI Securities , Ltd.#20 · 1 sh | 1 | $0.00 | — | 0.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.